Gout Therapeutics Market

1. Gout Therapeutics Market Market USD 6,304.8 million by 2026 | CAGR: 14.8%

2. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 “According to Polaris Market Research report, Gout Therapeutics Market is witnessing major innovations & transformations and is anticipated to reach USD 6,304.8 million by 2026, registering a CAGR of 14.8% during the forecast period 2020 to 2026. The global Gout Therapeutics Market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2026 The market analysis covered in the report includes data in terms of value $6,304.8 Million. The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market. Gout Therapeutics Market Report Scope: The global Gout Therapeutics Market is segmented based on drug class, disease condition, and geographic region. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market. - 2 -

3. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 By Drug Class By Disease By Region Type Condition • • • Non-steroidal Anti- Acute North America (U.S., Canada) • • Inflammatory Drugs Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) Chronic • (NSAIDs) Asia Pacific (Japan, China, India, Malaysia, Indonesia, South • Corticosteroids Korea) • • Colchicine Latin America (Brazil, Mexico, Argentina) • • Urate Lowering Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Agents COVID-19 Impact Analysis for Gout Therapeutics Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its long- term effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Gout Therapeutics Market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities : Browse Detailed Research Report On Gout Therapeutics Market Analysis: https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics-market Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service. - 3 -

4. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 Competitive Landscape The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Gout Therapeutics Market include AstraZeneca, Horizon Pharma Plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc, Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics- market/request-for-sample Table of Contents 1.Chapter 1. Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Chapter 2. Executive Summary 2.1.Market Highlights 3.Chapter 3. Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Chapter 4. Market Analysis 4.1.Overview 4.2.Gout Therapeutics Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. 4.2.1.2. 4.2.1.3. 4.2.2.Restraints and Challenges 4.2.2.1. 4.2.2.2. 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats Of New Entrants: (High) 4.3.3.Bargaining Power Of Buyers (High) 4.3.4.Threats Of Substitute (Moderate) 4.3.5.Rivalry Among The Existing Competitors (Moderate) Growing Geriatric Population Increasing incidence and prevalence of gout Growing research and development activities High cost of new and improved drugs Patent expiry of various blockbuster drugs - 4 -

5. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 4.4.PESTLE Analysis 4.5.Gout Therapeutics Market Industry trends 4.5.1.Newer treatments for gout 4.6.Competitive Ranking Analysis 5.Chapter 5. Gout Therapeutics Market Assessment by Drug Class 5.1.KEY FINDINGS 5.2.Introduction 5.2.1.Global Gout Therapeutics Market, By Type, 2015 – 2026 (USD Million) 5.3.Non-steroidal Anti-Inflammatory Drugs (NSAIDs) 5.3.1.Global Gout Therapeutics NSAIDs Market, by Region, 2015-2026 (USD Million) 5.3.2.North America: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.3.Europe: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.4.Asia-Pacific: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.5.LATAM: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.6.MEA: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.4.Corticosteroids 5.4.1.Global Gout Therapeutics Corticosteroids Market, by Region, 2015-2026 (USD Million) 5.4.2.North America: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.3.Europe: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.4.Asia-Pacific: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.5.LATAM: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.6.MEA: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.5.Colchicine 5.5.1.Global Gout Therapeutics Colchicine Market, by Region, 2015-2026 (USD Million) 5.5.2.North America: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.3.Europe: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.4.Asia-Pacific: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.5.LATAM: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.6.MEA: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.6.Urate Lowering Agents 5.6.1.Global Gout Therapeutics Urate Lowering Agents Market, by Region, 2015-2026 (USD Million) 5.6.2.North America: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) 5.6.3.Europe: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) 5.6.4.Asia-Pacific: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) 5.6.5.LATAM: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) 5.6.6.MEA: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) 6.Chapter 6. Gout Therapeutics Market Assessment by Disease Condition 6.1.KEY FINDINGS 6.2.Introduction 6.2.1.Global Gout Therapeutics Market, By Disease Condition, 2015 – 2026 (USD Million) 6.3.Acute Gout 6.3.1.Global Acute Gout Therapeutics Market, by Region, 2015-2026 (USD Million) 6.3.2.North America: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.3.3.Europe: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.3.4.Asia-Pacific: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.3.5.LATAM: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) - 5 -

6. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 6.3.6.MEA: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.Chronic 6.4.1.Global Chronic Gout Therapeutics Market, by Region, 2015-2026 (USD Million) 6.4.2.North America: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.3.Europe: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.4.Asia-Pacific: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.5.LATAM: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.6.MEA: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.Chapter 7. Gout Therapeutics Market Assessment by Geography 7.1.KEY FINDINGS 7.2.Introduction 7.2.1.Gout Therapeutics Market Assessment, By Geography, 2015-2026 (USD Million) 7.3.NORTH AMERICA 7.3.1.North America: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.3.2.North America: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.3.3.North America: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.3.4.U.S. 7.3.4.1. U.S.: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.3.4.2. U.S.: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.3.5.Canada 7.3.5.1. Canada: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.3.5.2. Canada: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.EUROPE 7.4.1.Europe: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.4.2.Europe: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.3.Europe: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.4.Germany 7.4.4.1. Germany: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.4.2. Germany: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.5.UK 7.4.5.1. UK: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.5.2. UK: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.6.France 7.4.6.1. France: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.6.2. France: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.7.Italy 7.4.7.1. Italy: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.7.2. Italy: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.8.Spain 7.4.8.1. Spain: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.8.2. Spain: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.9.Belgium 7.4.9.1. Belgium: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.9.2. Belgium: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.10.Rest of Europe 7.4.10.1. Rest of Europe: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.10.2. Rest of Europe: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.ASIA-PACIFIC 7.5.1.Asia Pacific: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.5.2.Asia Pacific: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) - 6 -

7. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 7.5.3.Asia Pacific: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.4.China 7.5.4.1. China: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.4.2. China: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.5.India 7.5.5.1. India: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.5.2. India: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.6.Japan 7.5.6.1. Japan: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.6.2. Japan: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.7.South Korea 7.5.7.1. South Korea: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.7.2. South Korea: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.8.Australia 7.5.8.1. Australia: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.8.2. Australia: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.9.Rest of APAC 7.5.9.1. Rest of APAC: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.9.2. Rest of APAC: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.6.LATIN AMERICA 7.6.1.Latin America: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.6.2.Latin America: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.3.Latin America: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.6.4.Brazil 7.6.4.1. Brazil: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.4.2. Brazil: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.6.5.Mexico 7.6.5.1. Mexico: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.5.2. Mexico: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.6.6.Rest of LATAM 7.6.6.1. Rest of LATAM: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.6.2. Rest of LATAM: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.7.MIDDLE EAST AND AFRICA 7.7.1.Middle East & Africa: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.7.2.Middle East & Africa: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.7.3.Middle East & Africa: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.7.4.South Africa 7.7.4.1. South Africa: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.7.4.2. South Africa: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.7.5.Saudi Arabia 7.7.5.1. Saudi Arabia: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.7.5.2. Saudi Arabia: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.7.6.Rest of Middle East and Africa 7.7.6.1. Rest of MEA: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) - 7 -

8. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 7.7.6.2. Rest of MEA: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 8.Chapter 8. Competitive Landscape 8.1.Agreements, Collaborations, Product Developments and launch Analysis 8.1.1.Strategic Analysis – Gout Therapeutics Market 8.2.Prouct/Service Launch 8.3.Partnerships/Collaborations/Agreements 8.4.Approvals 8.5.Others 9.Chapter 9. Company Profiles 9.1.AstraZeneca 9.1.1.Business Overview 9.1.2.Financial Snapshot 9.1.3.Products and Services 9.1.4.Recent Developments 9.2.Horizon Pharma Plc 9.2.1.Business Overview 9.2.2.Financial Snapshot 9.2.3.Products and Services 9.2.4.Recent Developments 9.3.Takeda Pharmaceutical Company Limited 9.3.1.Business Overview 9.3.2.Financial Snapshot 9.3.3.Products and Services 9.3.4.Recent Developments 9.4.GlaxoSmithKline plc 9.4.1.Business Overview 9.4.2.Financial Snapshot 9.4.3.Products and Services 9.4.4.Recent Developments 9.5.Novartis AG 9.5.1.Business Overview 9.5.2.Financial Snapshot 9.5.3.Products and Services 9.5.4.Recent Developments 9.6.Merck & Co. Inc. 9.6.1.Business Overview 9.6.2.Financial Snapshot 9.6.3.Products and Services 9.6.4.Recent Developments 9.7.Teijin Pharma Limited 9.7.1.Business Overview 9.7.2.Financial Snapshot 9.7.3.Products and Services 9.7.4.Recent Developments 9.8.Regeneron Pharmaceuticals, Inc. 9.8.1.Business Overview 9.8.2.Financial Snapshot 9.8.3.Products and Services 9.8.4.Recent Developments 9.9.Ironwood Pharmaceuticals, Inc. - 8 -

9. Gout Therapeutics Market Size Worth USD 6,304.8 million by 2026 9.9.1.Business Overview 9.9.2.Financial Snapshot 9.9.3.Products and Services 9.9.4.Recent Developments 9.10. JW Pharmaceutical 9.10.1.Business Overview 9.10.2.Financial Snapshot 9.10.3.Products and Services 9.10.4.Recent Developments 9.11. Selecta Biosciences, Inc. 9.11.1.Business Overview 9.11.2.Financial Snapshot 9.11.3.Products and Services 9.11.4.Recent Developments 9.12. Grunenthal Group 9.12.1.Business Overview 9.12.2.Financial Snapshot 9.12.3.Products and Services 9.12.4.Recent Developments Access Press Release on Gout Therapeutics Market: https://www.polarismarketresearch.com/press- releases/global-gout-therapeutics-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 9 -